EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of total neoadjuvant therapy regimens on radiation-induced lymphopenia in locally advanced rectal cancer: a retrospective analysis

Rie Sasaki, Senzo Taguchi iD, Hikaru Miyauchi, Yasuo Yoshioka, Eiji Shinozaki, Kensei Yamaguchi iD, Tomohiro Yamaguchi iD, Takashi Akiyoshi iD, Seno Satoshi, Takeaki Ishihara, Daisuke Miyawaki, Ryohei Sasaki

Journal of Radiation Research · 25.11.2025 · 66 (6) · 707-718

DOI: 10.1093/jrr/rraf069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Radiation Research, online erschienen am 18.11.2025. Verfasst von Rie Sasaki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. Hauptthemen laut MEDLINE: Lymphopenia, Rectal Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Grants-in-Aid for Exploratory Research, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Total neoadjuvant therapy (TNT) improves oncological outcomes in locally advanced rectal cancer (LARC); however, treatment-induced lymphopenia remains a concern. We analyzed 74 patients undergoing three TNT regimens: long-course chemoradiotherapy with consolidation chemotherapy (LCCRT–CNCT), short-course radiotherapy with CNCT (SCRT–CNCT), and induction chemotherapy with LCCRT (INCT–LCCRT). Severe radiation-induced lymphopenia (RIL, Grade ≥ 3) occurred in 48%, 24%, and 54%, respectively (P = 0.126). In the LCCRT–CNCT group, large bowel irradiation (V35 Gy > 46 cc) was significantly associated with severe RIL in univariable analysis but not in multivariable models (P = 0.227), and in an exploratory combined analysis of LCCRT–CNCT and INCT–LCCRT, this showed a trend (P = 0.093). Pre-TNT absolute lymphocyte count (ALC) was an independent predictor of RIL. Small bowel irradiation (V15 Gy > 104 cc) predicted severe lymphopenia during chemotherapy in the univariable analysis; but multivariable analysis suggested pre-TNT ALC as the main factor, showing a trend toward significance (P = 0.051). In the SCRT–CNCT group, pre-TNT ALC was the only significant factor for severe lymphopenia in both the RT and chemotherapy phases in univariable analysis. Severe RIL significantly prolonged lymphocyte recovery time (median, 283 vs. 76 days, P < 0.001), whereas immune recovery did not differ according to the TNT regimen. The median ALC at the last follow-up was 86% of the baseline value, indicating incomplete recovery. While pre-TNT ALC correlated with lymphopenia risk, minimizing bowel irradiation may help mitigate treatment-induced immunosuppression. Prospective studies are required to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphopeniaRectal NeoplasmsNeoadjuvant TherapyHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultChemoradiotherapy

Stichwörter der Autor:innen

bowel radiation doseimmunosuppressionlocally advanced rectal cancerlymphocyte recoveryradiation-induced lymphopeniatotal neoadjuvant therapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
  • Division of Radiation Oncology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
  • Department of Radiology, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
  • Rectal Cancer Multidisciplinary Treatment Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
  • Department of Gastroenterological Chemotherapy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
  • Department of Colorectal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

ORCID-Profile: Senzo Taguchi, Kensei Yamaguchi, Tomohiro Yamaguchi, Takashi Akiyoshi

Förderung

  • Grants-in-Aid for Exploratory Research
  • Ministry of Education

Zitieren

APA

Sasaki, R., Taguchi, S., Miyauchi, H., Yoshioka, Y., Shinozaki, E., Yamaguchi, K., Yamaguchi, T., Akiyoshi, T., Satoshi, S., Ishihara, T., Miyawaki, D., & Sasaki, R. (2025). Impact of total neoadjuvant therapy regimens on radiation-induced lymphopenia in locally advanced rectal cancer: a retrospective analysis. Journal of Radiation Research, 66(6), 707-718. https://doi.org/10.1093/jrr/rraf069

Vancouver

Sasaki R, Taguchi S, Miyauchi H, Yoshioka Y, Shinozaki E, Yamaguchi K, et al. Impact of total neoadjuvant therapy regimens on radiation-induced lymphopenia in locally advanced rectal cancer: a retrospective analysis. Journal of Radiation Research. 2025;66(6):707-718. doi:10.1093/jrr/rraf069

BibTeX
@article{Sasaki2025,
  author = {Sasaki, Rie and Taguchi, Senzo and Miyauchi, Hikaru and Yoshioka, Yasuo and Shinozaki, Eiji and Yamaguchi, Kensei and Yamaguchi, Tomohiro and Akiyoshi, Takashi and Satoshi, Seno and Ishihara, Takeaki and Miyawaki, Daisuke and Sasaki, Ryohei},
  title = {Impact of total neoadjuvant therapy regimens on radiation-induced lymphopenia in locally advanced rectal cancer: a retrospective analysis},
  journal = {Journal of Radiation Research},
  year = {2025},
  volume = {66},
  number = {6},
  pages = {707--718},
  doi = {10.1093/jrr/rraf069}
}
Kostenlos starten →